We’ve followed electric car battery maker A123 from near the beginning, and now it seems to be near its end. On Friday, the company told investors that it only has four to five months of cash left, provided it gets access to an expected $30 million.
A123 is looking for ways to cut costs and raise more money. While the company has promising battery technology and orders from major automakers, it has been plagued by high manufacturing costs (it lost 57 cents per dollar of revenue), cancelled orders, and recalls of faulty batteries.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.